| Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice A Zimmer, AM Zimmer, AG Hohmann, M Herkenham, TI Bonner Proceedings of the National Academy of Sciences 96 (10), 5780-5785, 1999 | 1303 | 1999 |
| An endocannabinoid mechanism for stress-induced analgesia AG Hohmann, RL Suplita, NM Bolton, MH Neely, D Fegley, R Mangieri, ... Nature 435 (7045), 1108-1112, 2005 | 867 | 2005 |
| The endocannabinoid system and pain J Guindon, AG Hohmann CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2009 | 574 | 2009 |
| Altered nociceptive neuronal circuits after neonatal peripheral inflammation MA Ruda, QD Ling, AG Hohmann, YB Peng, T Tachibana Science 289 (5479), 628-630, 2000 | 545 | 2000 |
| Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain J Guindon, AG Hohmann British journal of pharmacology 153 (2), 319-334, 2008 | 509 | 2008 |
| Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-α J LoVerme, R Russo, G La Rana, J Fu, J Farthing, G Mattace-Raso, ... Journal of Pharmacology and Experimental Therapeutics 319 (3), 1051-1061, 2006 | 382 | 2006 |
| Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism JR Clapper, G Moreno-Sanz, R Russo, A Guijarro, F Vacondio, A Duranti, ... Nature neuroscience 13 (10), 1265-1270, 2010 | 373 | 2010 |
| Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside EJ Rahn, AG Hohmann Neurotherapeutics 6 (4), 713-737, 2009 | 372 | 2009 |
| Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study AG Hohmann, M Herkenham Neuroscience 90 (3), 923-931, 1999 | 368 | 1999 |
| The cannabinoid system and pain SG Woodhams, V Chapman, DP Finn, AG Hohmann, V Neugebauer Neuropharmacology 124, 105-120, 2017 | 283 | 2017 |
| A double-blind, placebo-controlled, crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain ME Lynch, P Cesar-Rittenberg, AG Hohmann Journal of pain and symptom management 47 (1), 166-173, 2014 | 270 | 2014 |
| The endocannabinoid system and cancer: therapeutic implication J Guindon, AG Hohmann British journal of pharmacology 163 (7), 1447-1463, 2011 | 266 | 2011 |
| Targeting CB2 receptors and the endocannabinoid system for the treatment of pain P Anand, G Whiteside, CJ Fowler, AG Hohmann Brain research reviews 60 (1), 255-266, 2009 | 257 | 2009 |
| Cannabinoid receptors undergo axonal flow in sensory nerves AG Hohmann, M Herkenham Neuroscience 92 (4), 1171-1175, 1999 | 256 | 1999 |
| Endocannabinoid mechanisms of pain modulation AG Hohmann, RL Suplita The AAPS journal 8, E693-E708, 2006 | 255 | 2006 |
| Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: A double‐label in situ hybridization study AG Hohmann, M Herkenham Synapse 37 (1), 71-80, 2000 | 246 | 2000 |
| Pre-and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord AG Hohmann, EM Briley, M Herkenham Brain research 822 (1-2), 17-25, 1999 | 239 | 1999 |
| Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation AG Nackley, A Makriyannis, AG Hohmann Neuroscience 119 (3), 747-757, 2003 | 237 | 2003 |
| Cannabinoid mechanisms of pain suppression JM Walker, AG Hohmann Cannabinoids, 509-554, 2005 | 216 | 2005 |
| Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and … WJ Martin, AG Hohmann, JM Walker Journal of Neuroscience 16 (20), 6601-6611, 1996 | 212 | 1996 |
Alexandros MakriyannisNortheastern UniversityVerified email at northeastern.edu
